Abstract
No public abstract is available from the verified source records.
Pietro Ruggieri, Anna Breda, Andrea Angelini
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Controversies in orthopaedic oncology
10.1302/0301-620x.106b5.bjj-2023-1381 · 2024
A modified Delphi consensus on periprosthetic infection in orthopaedic oncology: a report from the Birmingham Orthopaedic Oncology Meeting (BOOM)
2025
Identifying consensus and areas for future research in chondrosarcoma: a report from the Birmingham Orthopaedic Oncology Meeting
10.1302/0301-620x.107b2.bjj-2024-0643.r1 · 2025
Chondrosarcoma: clinical behavior, molecular mechanisms, and emerging therapeutic strategies
10.1016/j.critrevonc.2025.105075 · 2026
Chondrosarcoma: a comprehensive review of tumor biology, clinical behavior, and therapeutic advances
10.1016/j.ctrv.2026.103197 · 2026
MiRNA-based expression signatures in differential diagnosis of enchondroma and chondrosarcoma
10.1016/j.jbo.2026.100761 · 2026
A deep learning model for classification of chondroid tumors on CT images
10.1186/s12885-025-13951-1 · 2025
Chondrosarcoma of the flat bones: differential survival between high-grade lesions of the pelvis and scapula
10.1002/jso.28023 · 2025
Core needle biopsy of periacetabular chondrosarcoma often results in undergrading but does not change management by experienced orthopaedic oncologists
10.1038/s41598-025-93246-4 · 2025
Enhancing surgical margins: a key to survival in pelvic chondrosarcoma
10.1016/j.ejso.2024.109491 · 2025
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma
10.1186/s13059-025-03812-2 · 2025
Are IDH1 R132 mutations associated with poor prognosis in patients with chondrosarcoma of the bone?
10.1097/corr.0000000000002960 · 2024
Prognostic role of TERT mutations in chondrosarcoma: associations with dedifferentiation, survival, and IDH/TERT co-mutations
10.3390/cancers18142272 · 2026
Phase I study of the mutant IDH1 inhibitor ivosidenib: long-term safety and clinical activity in patients with conventional chondrosarcoma
10.1158/1078-0432.ccr-24-4128 · 2025
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: Phase 1b/2 trial
10.1038/s41467-026-68716-6 · 2026
Giant cell tumor of bone: biology, pathophysiology, and histopathology in the era of H3F3A
10.3390/biomedicines14020449 · 2026
Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants
10.1016/j.jbo.2025.100728 · 2025
Exploring denosumab in the treatment of giant cell tumors: clinical evidence and controversies
10.1097/scs.0000000000010880 · 2025
[Update on the recommendations for the management and treatment of giant cell bone tumors, on behalf of GroupOS]
10.1016/j.bulcan.2024.01.013 · 2025
What’s new on giant cell tumor of bone
10.1051/sicotj/2025063 · 2026
Survival of modern knee tumor megaprostheses: failures, functional results, and a comparative statistical analysis
10.1007/s11999-014-3699-2 · 2015
What is the survival and function of modular reverse total shoulder prostheses in patients undergoing tumor resections in whom an innervated deltoid muscle can be preserved?
10.1097/corr.0000000000000899 · 2019
Current treatment options and emerging technologies for pelvic bone tumors: from limb salvage to precision oncology
10.1007/s11864-026-01406-z · 2026
Personalized 3D-printed prostheses for bone defect reconstruction after tumor resection in the foot and ankle
10.3390/jfb16020062 · 2025
Reconstruction with 3D-printed prostheses after type I + II + III internal hemipelvectomy: finite element analysis and preliminary outcomes
10.3389/fbioe.2022.1036882 · 2023
3D printing for patient-specific implants in musculoskeletal oncology
10.1530/eor-23-0066 · 2023
A retrospective study of 3D-printed custom titanium prostheses for reconstruction of bone defects after resection of pelvic tumors: technical points and early results
10.1186/s12893-025-03253-5 · 2025
Implementation of an intraoperative augmented reality environment for custom-made partial pelvis replacements-a proof of concept and initial results
10.3390/jpm16020124 · 2026
Reconstruction with 3D-printed pelvic endoprostheses after resection of a pelvic tumour
10.1302/0301-620x.99b2.bjj-2016-0654.r1 · 2017
Should the pelvic ring be closed after tumor resection? A systematic review
10.3390/cancers18111828 · 2026
New options and techniques in reconstructing the sacrum
10.1007/s00586-025-09058-7 · 2026
Modified spinopelvic fixation with a novel three-dimensional-printed element following total sacrectomy for patients with sacral tumours
10.1007/s00586-026-10008-0 · 2026
Can periprosthetic joint infection of tumor prostheses be controlled with debridement, antibiotics, and implant retention?
10.1097/corr.0000000000003184 · 2025
Microbiological characteristics and clinical outcomes of periprosthetic infections following oncologic megaprosthetic reconstruction: a retrospective cohort study
10.3390/pathogens15030306 · 2026
Debridement, antibiotics, and implant retention (DAIR) plus offers similar periprosthetic joint infection treatment success rates to two-stage revision in oncologic megaprosthesis
10.1016/j.arth.2024.01.021 · 2024
Treatment success of periprosthetic joint infections in oncologic endoprostheses after standardization of surgical strategies-a systematic review of the literature
10.5435/jaaos-d-25-00523 · 2026
BOOM Consortium. Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours: a systematic review and meta-analysis
10.1302/2633-1462.76.bjo-2026-0037.r1 · 2026
Surgical site infections following pelvic sarcoma reconstruction with 3D-printed implants: current concepts and future directions
10.1089/sur.2024.319 · 2025
Periacetabular resection for bone tumors: is there still a role for massive allograft-prosthesis composite reconstructions?
10.1097/corr.0000000000003754 · 2026
Bridging the gap: biological reconstruction with vascularised fibula, massive allograft, or Capanna technique after intercalary resection in children and young adults with lower limb bone sarcoma
2026
A survey to determine the zone of equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) randomized controlled trial
10.1186/s13063-024-08590-z · doi-reference
AAOS Clinical Practice Guideline Summary: treatment of metastatic carcinoma and myeloma of the femur
10.5435/jaaos-d-21-00888 · doi-reference
Sacral chordomas: surgical management, reconstruction, and translational advances: a systematic review
10.21037/jss-25-180 · doi-reference
Therapeutic strategies for mobile spine chordoma: en bloc versus intralesional surgery with adjuvant charged-particle therapy
10.1007/s11060-024-04841-w · doi-reference
Proton beam therapy for chordoma: a systematic review and meta-analysis
10.1016/j.critrevonc.2025.105013 · doi-reference
Global consensus on the management of primary localized chordoma
10.1001/jamaoncol.2026.2054 · doi-reference
Feasibility of nonspinal bony landmark-based image registration in CyberKnife ® robotic radiotherapy for pelvic and femoral bone tumors
10.1093/jrr/rrag028 · doi-reference
Bone metastases in NSCLC: modern paradigms in management and supportive care
10.1016/j.ctrv.2025.103051 · doi-reference
Peri-operative outcomes of IlluminOss fixation for pelvic metastatic bone disease
10.1016/j.jor.2024.09.016 · doi-reference
The IlluminOss photodynamic bone stabilization system: novel technology with broad application in orthopaedic fracture fixation
10.1080/17434440.2026.2627378 · doi-reference
The current role of cryoablation in the management of soft tissue and bone tumors: a narrative review
10.1016/j.clinimag.2025.110704 · doi-reference
Efficacy and safety of microwave ablation for the treatment of pulmonary osteosarcoma oligometastases
10.1080/02656736.2026.2620735 · doi-reference
Prognostic impact of oligometastases in orthopaedic surgery for metastatic bone disease
10.1177/10225536251315983 · doi-reference
Modern treatment of skeletal metastases: multidisciplinarity and the concept of oligometastasis in the recent literature
10.3390/curroncol32040226 · doi-reference
The bone microenvironment and therapeutic resistance in spinal metastases: mechanisms and clinical implications
10.1016/j.jocn.2026.111928 · doi-reference
Management of metastatic bone disease of the pelvis: current concepts
10.1007/s00068-023-02382-x · doi-reference
Pathologic fractures in primary bone tumors: a paradigm shift in management
10.1016/j.injury.2025.112853 · doi-reference
Prognostic biomarkers for overall survival in patients undergoing surgery for bone metastases: a pan-cancer study
10.3389/fmed.2025.1655245 · doi-reference
Staged reconstruction is not necessary following oncologic resection of superficial myxofibrosarcoma
10.3390/cancers17223637 · doi-reference
Ortho-oncoplastic surgery in foot and ankle: a narrative overview on reconstruction of soft-tissue defects after oncologic resections
10.1002/micr.31168 · doi-reference
Pedicled vastus lateralis myocutaneous flap for sacropelvic defects after wide oncologic resection: wound complications and outcomes
10.1002/jso.27006 · doi-reference
The role of orthoplastic surgery in musculoskeletal oncology
10.1530/eor-2025-0062 · doi-reference
Histologic and immunologic factors associated with response to immune checkpoint inhibitors in advanced sarcoma
10.1158/1078-0432.ccr-24-3485 · doi-reference
Current approaches to the treatment of pediatric soft tissue sarcomas: rhabdomyosarcoma and nonrhabdomyosarcoma soft tissue sarcomas
10.1016/j.hoc.2025.04.004 · doi-reference
Preoperative sequential chemotherapy and hypofractionated radiotherapy combined with comprehensive surgical resection for high-risk soft tissue sarcomas: a retrospective study
10.3389/fonc.2024.1423151 · doi-reference
Neoadjuvant or adjuvant chemotherapy in soft-tissue sarcoma?
10.1007/s11912-024-01630-6 · doi-reference
Precision medicine in diagnosis, prognosis, and disease monitoring of bone and soft tissue sarcomas using liquid biopsy: a systematic review
10.1007/s00402-024-05711-w · doi-reference
Advances in liquid biopsy for bone and soft-tissue sarcomas
10.1007/s10147-025-02813-2 · doi-reference
The application of orthopedic surgical robot-assisted technology in various clinical scenarios involving bone tumors
10.1111/os.70195 · doi-reference
Artificial intelligence in bone metastasis analysis: current advancements, opportunities and challenges
10.1016/j.compbiomed.2025.110372 · doi-reference
Artificial intelligence and machine learning in bone metastasis management: a narrative review
10.3390/curroncol33010065 · doi-reference
Accuracy of artificial intelligence in detecting tumor bone metastases: a systematic review and meta-analysis
10.1186/s12885-025-13631-0 · doi-reference
Intelligent nanomedicine systems utilizing diverse nanoparticles for osteosarcoma therapy: a review
10.2147/ijn.s560865 · doi-reference
Diagnostic performance of artificial intelligence in detection of hepatocellular carcinoma: a meta-analysis
10.1007/s10278-024-01058-1 · doi-reference
The emerging role of mixed reality and artificial intelligence in sarcoma care: a systematic review
10.1016/j.ejso.2026.111447 · doi-reference
Machine learning-assisted decision making in orthopaedic oncology
10.2106/jbjs.rvw.24.00057 · doi-reference
Long-term outcomes of computer navigation-assisted resection for primary pelvic sarcomas
10.1302/0301-620x.107b5.bjj-2024-0732.r2 · doi-reference
Targeting strategies and immune regulatory mechanisms of CAR-macrophages in the treatment of osteosarcoma
10.1016/j.coph.2025.102602 · doi-reference
Harnessing the immune responses: a new frontier in Ewing sarcoma treatment
10.1007/s12032-025-02848-5 · doi-reference
Reprogramming adoptive cell therapy for osteosarcoma: engineering, vaccination, and tumor microenvironment remodeling
10.3389/fimmu.2026.1865742 · doi-reference